Anabolic Androgenic Steroids and Carcinogenicity Focusing on Leydig Cell: A Literature Review

    April 2018 in “ Oncotarget
    Monica Salerno, Orazio Cascio, Giuseppe Bertozzi, Francesco Sessa, Antonietta Messina, Vincenzo Monda, Luigi Cipolloni, Antonio Biondi, Aurora Daniele, Cristoforo Pomara
    TLDR Anabolic androgenic steroids can increase cancer risk and disrupt hormones.
    This literature review examined the carcinogenic effects of anabolic androgenic steroids (AAS), particularly focusing on Leydig cell tumors. AAS were found to influence DNA transcription through androgen and estrogen receptors, potentially leading to cell proliferation in Leydig cell cancer and breast cell proliferation. The review highlighted the activation of pathways such as PI3K/AKT and PLC/PKC by steroids like nandrolone and stanazolol, contributing to these effects. The study emphasized the public health concern posed by AAS abuse, which disrupts testosterone biosynthesis and hormonal regulation, potentially leading to carcinogenic outcomes. The authors suggested that increased awareness campaigns in gyms and schools could help prevent male fertility issues and other tissue damage associated with AAS use.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results

    Related Community Posts Join

    6 / 198 results

    Similar Research

    5 / 848 results